>For more recent, though more vague, evidence that China may not share the same views on handling extremely dangerous pathogens as the rest of the world, we hav

>For more recent, though more vague, evidence that China may not share the same views on handling extremely dangerous pathogens as the rest of the world, we have this story from July 2019, wherein a Chinese researcher working in one of Canada's BS-4 labs, along with her husband who was a SARS researcher, as well as several students she brought over from China to work with her, were all given the boot over unspecified "administrative matters". She (and her husband) are both Canadian researchers who happens to be Chinese. She shipped Ebola and henipavirus samples with "all appropriate precautions" as part of "routine" sharing program according to National Microbiology Laboratory. They suspended her non-salaried appointments during current investigation, her students, some of whom were Chinese nationals, were reassigned. The IP concern was a Chinese Mabworks company was developing the experimental and patented ebola drug ZMapp which she worked on without authorization.